Increased risk of dermatological immune-related adverse events in cancer patients treated with immune checkpoint inhibitors

Authors

R. Chan, New York Medical College, Valhalla, NY
Rahib Islam, LSU Health Sciences Center - New OrleansFollow
A. Gross, Tulane University School of Medicine, New Orleans, LA
Hassan Malik, LSU Health Sciences Center - New OrleansFollow
Humza Pirzadah, LSU Health Sciences Center - New OrleansFollow
A. Abdelmaksoud, Tulane University School of Medicine, New Orleans, LA
Christopher Haas, LSU Health Sciences Center - New OrleansFollow
E. Toraih, Tulane University School of Medicine, New Orleans, LA
S. Lipner, Weill Cornell Medicine, New York, NY

Document Type

Conference Proceeding

Publication Date

7-21-2025

Publication Title

Journal of Investigative Dermatology

Abstract

Society for Investigative Dermatology (SID) 2025, May 7 - 10, 2025, San Diego, CA

First Page

S68

Volume

145

Issue

8, Supplement

Comments

Abstract 0400

Rights

© 2025 Published by Elsevier Inc.

Recommended Citation

Chan, R.; Islam, Rahib; Gross, A.; Malik, Hassan; Pirzadah, Humza; Abdelmaksoud, A.; Haas, Christopher; Toraih, E.; and Lipner, S., "Increased risk of dermatological immune-related adverse events in cancer patients treated with immune checkpoint inhibitors" (2025). School of Medicine Faculty Publications. 4096.
https://digitalscholar.lsuhsc.edu/som_facpubs/4096
10.1016/j.jid.2025.06.404